Evidence map›Paper›PMID 36638133›Full record

ArticlePLoS neglected tropical diseases2023

Effects of Clonorchis sinensis combined with Hepatitis B virus infection on the prognosis of patients with Hepatocellular Carcinoma following Hepatectomy.

Yuan-Kuan Li, Jing-Fei Zhao, Cheng-Lei Yang, Guo-Hua Zhan, Jie Zhang, Shang-Dong Qin, Min Zhou, Min-Jun Li, Jun-Tao Huang, Feng-Yao Kong and 3 more

Abstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Frontiers in cellular and infection microbiology · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Frontiers in immunology · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Yuan-Kuan LiDepartment of Hepatobiliary Surgery, Guangxi Medical University Affiliated Tumor Hospital, Guangxi, China.ORCID 0000-0001-7101-1530
Jing-Fei ZhaoDepartment of Hepatobiliary Surgery, Guangxi Medical University Affiliated Tumor Hospital, Guangxi, China.
Cheng-Lei YangDepartment of Hepatobiliary Surgery, Guangxi Medical University Affiliated Tumor Hospital, Guangxi, China.
Guo-Hua ZhanDepartment of Hepatobiliary Surgery, Guangxi Medical University Affiliated Tumor Hospital, Guangxi, China.
Jie ZhangDepartment of Hepatobiliary Surgery, Guangxi Medical University Affiliated Tumor Hospital, Guangxi, China.
Shang-Dong QinDepartment of Hepatobiliary Surgery, Guangxi Medical University Affiliated Tumor Hospital, Guangxi, China.
Min ZhouDepartment of Hepatobiliary Surgery, Guangxi Medical University Affiliated Tumor Hospital, Guangxi, China.
Min-Jun LiDepartment of Hepatobiliary Surgery, Guangxi Medical University Affiliated Tumor Hospital, Guangxi, China.
Jun-Tao HuangDepartment of Hepatobiliary Surgery, Guangxi Medical University Affiliated Tumor Hospital, Guangxi, China.
Feng-Yao KongDepartment of Hepatobiliary Surgery, Guangxi Medical University Affiliated Tumor Hospital, Guangxi, China.
Hai HuangDepartment of Hepatobiliary Surgery, Guangxi Medical University Affiliated Wuming Hospital, Guangxi, China.
Jia-Hao ChenDepartment of Hepatobiliary Surgery, Guangxi Medical University Affiliated Wuming Hospital, Guangxi, China.
Bang-De XiangDepartment of Hepatobiliary Surgery, Guangxi Medical University Affiliated Tumor Hospital, Guangxi, China.ORCID 0000-0002-2758-1437

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis study aimed to determine the impact of co-infection of Clonorchis sinensis (CS) and hepatitis B virus (HBV) on the prognosis of patients with hepatocellular carcinoma (HCC) following hepatectomy.

methodsThe clinicopathological information of 946 patients with HCC following hepatectomy was retrospectively analyzed. The patients were divided into four groups depending on whether they had CS infection and/or HBV infection: double-negative group (infected with neither CS nor HBV), simple CS group (infected with only CS), simple HBV group (infected with only HBV), and double-positive group (co-infected with CS and HBV). Kaplan-Meier curves were used to evaluate the overall survival (OS) and recurrence-free survival (RFS), while log-rank tests were used to compare survival rates. Further, Cox regression was used to perform both univariate and multivariate survival analyses to identify variables linked to the prognosis of HCC.

resultsThe median overall survival (OS) and recurrence-free survival (RFS) in the double-positive, simple CS, simple HBV, and double-negative groups were 27 months and 9 months, 20 months and 7 months, 44 months and 12 months, and 42 months and 17 months, respectively. The double-positive group's 1-year, 3-year, and 5-year OS and RFS rates were 79.2% and 46.9%, 62.6% and 28.4%, 47.8%, and 12.2%, respectively. The simple CS group's 1-year, 3-year, and 5-year OS and RFS rates were 86.3% and 41.5%, 56.5% and 27.7%, 50.2%, and 18.5%, respectively. The simple HBV group's 1-year, 3-year, and 5-year OS and RFS rates were 89.8% and 56.0%, 72.5% and 30.5%, 63.8%, and 19.9%, respectively. The double-negative group's 1-year, 3-year, and 5-year OS and RFS rates were 91.5% and 62.3%, 76.1% and 32.9%, 64.0%, and 22.4%, respectively. Further, according to a Cox multivariate analysis, tumor size (> 5cm), Edmonson grade (III-IV), BCLC-C stage, and tumor satellite focus were independent risk factors for RFS and OS in patients with HCC.

conclusionPatients with HCC and Clonorchis sinensis infection experience a poor prognosis after hepatectomy, regardless of whether they are co-infected with HBV.

Indexed as

Carcinoma, HepatocellularClonorchis sinensisHepatitis BLiver NeoplasmsAnimalsDisease-Free SurvivalHepatectomyHepatitis B virusHumansPrognosisRetrospective Studies

Identifiers

PMID36638133
PMCPMC9879467

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.